Have a personal or library account? Click to login
The Influence of Specialist Palliative Care in Aggressive End of Life Management of Patients with Advanced Cancer Cover

The Influence of Specialist Palliative Care in Aggressive End of Life Management of Patients with Advanced Cancer

Open Access
|Mar 2026

References

  1. Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical practice guideline update. Journal of Clinical Oncology. 2017 Jan 1;35(1):96–112. doi: 10.1200/JCO.2016.70.1.
  2. Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, et al. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol. 2018 Nov;19(11):e588–e653. doi: 10.1016/S1470-2045(18)30415-7.
  3. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? Journal of Clinical Oncology. 2008 Aug 10;26(23):3860–3866. doi: 10.1200/jco.2007.15.8253.
  4. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733–742. doi: 10.1056/nejmoa1000678.
  5. Cherny NI, Nortjé N, Kelly R, Zimmermann C, Jordan K, Kreye G, et al. A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed? ESMO Open. 2025 Jan;10(1):104099. doi: 10.1016/j.esmoop.2024.104099.
  6. Abedini NC, Hechtman RK, Singh AD, Khateeb R, Mann J, Townsend W, et al. Interventions to reduce aggressive care at end of life among patients with cancer: A systematic review. Lancet Oncol. 2019 Nov;20(11):e627–e636. doi: 10.1016/S1470-2045(19)30496-6.
  7. Bylicki O, Didier M, Riviere F, Margery J, Grassin F, Chouaid C. Lung cancer and end-of-life care: A systematic review and thematic synthesis of aggressive inpatient care. BMJ Support Palliat Care. 2019 Dec;9(4):413–424. doi: 10.1136/bmjspcare-2019-001770.
  8. Massa I, Nanni O, Foca F, Maltoni M, Derni S, Gentili N, et al. Chemotherapy and palliative care near end-of life: Examining the appropriateness at a cancer institute for colorectal cancer patients. BMC Palliat Care. 2018 Dec 19;17(1):86. doi: 10.1186/s12904-018-0339-8.
  9. Wright AA, Keating NL, Ayanian JZ, Chrischilles EA, Kahn KL, Ritchie CS, et al. Family perspectives on aggressive cancer care near the end of life. JAMA. 2016 Jan 19; 315(3):284. doi: 10.1001/jama.2015.18604.
  10. Earle CC, Neville BA, Landrum MB, Souza JM, Weeks JC, Block SD, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005 Dec 1;17(6):505–509. doi: 10.1093/intqhc/mzi061.
  11. García-Martín E, Escudero-Vilaplana V, Fox B, Collado-Borrell R, Marzal-Alfaro B, Sánchez-Isac M, et al. Aggressiveness of end-of-life cancer care: What happens in clinical practice? Support Care Cancer. 2021 Jun 16;29(6):3121–3127. doi: 10.1007/s00520-020-05828-9.
  12. Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009 Sep;20(9):1555–1559. doi: 10.1093/annonc/mdp027.
  13. Golob N, Oblak T, Čavka L, Kušar M, Šeruga B. Aggressive anticancer treatment in the last 2 weeks of life. ESMO Open. 2024 Mar;9(3):102937. doi: 10.1016/j.esmoop.2024.102937.
  14. Zadnik V, Zagar T, Lokar K, Tomsic S, Konjevic AD, Zakotnik B. Trends in population-based cancer survival in Slovenia. Radiol Oncol. 2021 Jan 21;55(1):42–49. doi: 10.2478/raon-2021-0003.
  15. Bylicki O, Rivière F, Tournier C, Canoui-Poitrine F, Grassin F, Margery J, et al. Factors associated with aggressiveness of end-of-life care for lung cancer patients and associated costs of care. Clin Lung Cancer. 2021 May;22(3):e320–e328. doi: 10.1016/j.cllc.2020.05.017.
  16. Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. Journal of Clinical Oncology. 2011 Apr 20;29(12):1587–1591. doi: 10.1200/JCO.2010.31.9897.
  17. Abdel-Razeq H, Shamieh O, Abu-Nasser M, Nassar M, Samhouri Y, Abu-Qayas B, et al. Intensity of cancer care near the end of life at a tertiary care cancer center in Jordan. J Pain Symptom Manage. 2019 Jun;57(6):1106–1113. doi: 10.1016/j.jpainsymman.2019.02.016.
  18. Barbera L, Paszat L, Chartier C. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care. 2006;22(1):12–17.
  19. Soh TIP, Yuen YC, Teo C, Lim SW, Chan N, Wong ASC. Targeted therapy at the end of life in advanced cancer patients. J Palliat Med. 2012 Sep;15(9):991–997. doi: 10.1089/jpm.2012.0050.
  20. Hui D, Karuturi MS, Tanco KC, Kwon JH, Kim SH, Zhang T, et al. Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage. 2013 Jul;46(1):1–8. doi: 10.1016/j.jpainsymman.2012.07.007.
  21. Tsai HY, Chung KP, Kuo RNC. Impact of targeted therapy on the quality of end-of-life care for patients with non–small-cell lung cancer: A population-based study in Taiwan. J Pain Symptom Manage. 2018 Mar;55(3):798–807. doi: 10.1016/j.jpainsymman.2017.10.009.
  22. Tsuchiya M, Obara T, Kikuchi M, Mano N. The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database. Cancer Chemother Pharmacol. 2023 Jun 8;91(6):501–506. doi: 10.1007/s00280-023-04535-6.
  23. Merchant SJ, Lajkosz K, Brogly SB, Booth CM, Nanji S, Patel S V, et al. The final 30 days of life: A study of patients with gastrointestinal cancer in Ontario, Canada. J Palliat Care. 2017 Jul 8;32(3–4):92–100. doi: 10.1177/0825859717738464.
  24. Duggan KT, Hildebrand Duffus S, D’Agostino RB, Petty WJ, Streer NP, Stephenson RC. The impact of hospice services in the care of patients with advanced stage nonsmall cell lung cancer. J Palliat Med. 2017 Jan 1;20(1):29–34. doi: 10.1089/jpm.2016.0064.
  25. Tang ST, Wu SC, Hung YN, Huang EW, Chen JS, Liu TW. Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Ann Oncol. 2009 Feb;20(2):343–348. doi: 10.1093/annonc/mdn602.
  26. Orlovic M, Marti J, Mossialos E. Analysis of end-of-life care, out-of-pocket spending, and place of death in 16 European countries and Israel. Health Aff. 2017 Jul;36(7):1201–1210. doi: 10.1377/hlthaff.2017.0166.
  27. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. Journal of Clinical Oncology. 2004 Jan 15;22(2):315–321. doi: 10.1200/JCO.2004.08.136.
  28. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, et al. Who gets chemotherapy for metastatic lung cancer? Chest. 2000 May;117(5):1239–1246. doi: 10.1378/chest.117.5.1239.
  29. Sheng J, Zhang YX, He XB, Fang WF, Yang YP, Lin GN, et al. Chemotherapy near the end of life for chinese patients with solid malignancies. Oncologist. 2017 Jan;22(1):53–60. doi: 10.1634/theoncologist.2016-0013.
  30. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among medicare beneficiaries at the end of life. Ann Intern Med. 2003 Apr 15;138(8):639. doi: 10.7326/0003-4819-138-8-200304150-00011.
  31. Chiaruttini MV, Corli O, Pizzuto M, Nobili A, Fortini G, Fortino I, et al. Palliative medicine favourably influences end-of-life cancer care intensity: A large retrospective database study. BMJ Support Palliat Care. 2024 May;14(e1):e1293–e1301. doi: 10.1136/spcare-2022-004050.
  32. Le NS, Zeybek A, Hackner K, Gottsauner-Wolf S, Groissenberger I, Jutz F, et al. Systemic anticancer therapy near the end of life: An analysis of factors influencing treatment in advanced tumor disease. ESMO Open. 2024 Sep;9(9):103683. doi: 10.1016/j.esmoop.2024.103683.
  33. World Health Organisation. Palliative care [Internet]. 2025 [cited 2025 Aug 20]. Available at: https://www.who.int/news-room/fact-sheets/detail/palliative-care
  34. Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer. 2008 Aug 15;113(4):826–833. doi: 10.1002/cncr.23620.
  35. Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E. Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer. 2014 Jun 22;120(11):1743–1749. doi: 10.1002/cncr.28628.
  36. Chen H, Haley WE, Robinson BE, Schonwetter RS. Decisions for hospice care in patients with advanced cancer. J Am Geriatr Soc. 2003 Jun;51(6):789–797. doi: 10.1046/j.1365-2389.2003.51252.x.
  37. Bluhm M, Connell CM, De Vries RG, Janz NK, Bickel KE, Silveira MJ. Paradox of prescribing late chemotherapy: Oncologists explain. J Oncol Pract. 2016 Dec;12(12):e1006–e1015. doi: 10.1200/JOP.2016.013995.
  38. Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliat Med. 2000 Jul 1;14(5):363–374. doi: 10.1191/026921600701536192.
  39. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations—a study by the steering committee of the European Association for Palliative Care. Journal of Clinical Oncology. 2005 Sep 1;23(25):6240–6248. doi: 10.1200/JCO.2005.06.866.
  40. Hu W, Yasui Y, White J, Winget M. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006–2009. J Pain Symptom Manage. 2014 Feb;47(2):231–244. doi: 10.1016/j.jpainsymman.2013.03.021.
  41. Ministrstvo za zdravje Republike Slovenije. Paliativna oskrba [Internet]. 2025 [cited 2025 Aug 20]. Available at: https://www.gov.si/teme/paliativna-oskrba/
  42. Zdravniška zbornica Slovenije. Stanje paliativne oskrbe v Sloveniji [Internet]. 2018 [cited 2025 Aug 20]. Available at: https://www.zdravniskazbornica.si/docs/default-source/isis/golob-nena_stanje-paliativne-oskrbe-v-sloveniji_splet_isis-7-2019.pdf?sfvrsn=63f33136_2
DOI: https://doi.org/10.2478/sjph-2026-0007 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 51 - 58
Submitted on: Sep 30, 2025
|
Accepted on: Jan 20, 2026
|
Published on: Mar 1, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Nena Golob, Teja Oblak, Boštjan Šeruga, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution 4.0 License.